Filter by

Filter by
Regions & Countries:Austria X
  • Novartis opens global production facility for innovative retina drug in Tyrol

    Content Types: ArticleRegions & Countries: AustriaSwitzerlandIndustries: Pharma/BiotechMedical & Health
    Starting in 2021, Novartis will exclusively produce a new retina drug at its Tyrolean plant in Kundl, designed to combat wet age-related macular degeneration.
  • Business Location Austria on the fast track

    Content Types: ArticleRegions & Countries: AustriaIndustries: All
    Competitiveness: In a comparison of 63 countries, Austria moved up three notches, from 19th to 16th place, thus overtaking Germany.
  • Bosch continues its strong commitment to Austria

    Content Types: ArticleRegions & Countries: AustriaGermanyIndustries: Information Technology
    In 2019 Bosch made considerable investments of capital and human resources at its Austrian sites. It is attaching particular emphasis on R&D.
  • BMW invested € 374 million in Austria in 2019

    Content Types: ArticleRegions & Countries: AustriaGermanyIndustries: Automotive
    In 2019, BMW invested € 374 million in the Austrian production facility in Steyr which manufactures close to half of all BMW engines.
  • Austria as an attractive investment location

    Content Types: ArticleRegions & Countries: AustriaServices: Investment Promotion
    EY Attractiveness Survey: Austria registered a record year as an investment location in 2019, showing an increase of 73%.
  • Biobank Graz builds up a collection of COVID-19 samples

    Content Types: ArticleRegions & Countries: AustriaIndustries: Pharma/BiotechMedical & Health
    The Biobank of the Medical University of Graz is building up a collection of COVID-19 samples in order to further develop testing procedures and also conduct research into prognosis markers for the progression of the disease.
  • Coronavirus: Government Commits € 23 Million to Fund Drug Research

    Content Types: ArticleRegions & Countries: AustriaIndustries: Pharma/BiotechMedical & Health
    The Austrian Federal Government is making € 23 million in funding available for drug research to fight the coronavirus. The financial support primarily targets projects designed to conduct research into the effectiveness of existing drugs as a means of combatting the coronavirus. The additional funding is designed to accelerate the required clinical studies.
  • Corona: Government Aid for Companies

    Content Types: ArticleRegions & Countries: AustriaIndustries: Medical & Health
    The current restrictions by the Austrian government for combating the COVID-19-pandemic lead to several complex legal and tax questions. Deloitte advisors respectively Jank Weiler Operenyi / Deloitte Legal advisors inform you about possible legal and tax implications and developments.
  • Infineon expands chip production in Austria

    Content Types: ArticleRegions & Countries: AustriaGermanyIndustries: Manufacturing
    The German chip manufacturer Infineon is massively expanding its capacities in Austria.
  • Google prize for Tyrolean quantum physicist

    Content Types: ArticleRegions & Countries: AustriaIndustries: Information Technology
    The Tyrolean physicist Wolfgang Lechner has been granted a Google Faculty Research Award in the category Quantum Computing.

Featured Members

  • Mergermarket is an independent Mergers and Acquisitions (M&A) intelligence service with an unrivalled network...
  • ABA–Invest in Austria, the national investment promotion agency of the Republic of Austria, is the first point of...

View More

Top